Latest Us Market News

Page 1 of 84
Blue Star Helium has shipped its second helium trailer under a fixed offtake agreement, signalling stable production and a shift towards regular sales from its Galactica Project in Colorado. The company is targeting a production ramp-up through drilling and plant optimisation in the second half of 2026.
Maxwell Dee
Maxwell Dee
28 July 2026
LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.
Victor Sage
Victor Sage
28 July 2026
ImpediMed reported a 3% revenue increase to $3.6 million in Q4 FY26, bolstered by a $15.3 million capital raise and strategic leadership hires as it pushes growth in cancer survivorship, heart health, and weight management.
Ada Torres
Ada Torres
28 July 2026
Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.
Ada Torres
Ada Torres
27 July 2026
FBR Limited has partnered with Industrial Robotics LLC to distribute and support its Mantis™ welding robots across the United States and Canada, targeting key southern states and expanding its footprint without increasing headcount.
Victor Sage
Victor Sage
27 July 2026
AML3D Limited closed FY26 with a record $29 million order book, driven by US defence contracts and a $12 million investment to double its Ohio manufacturing capacity. The company’s cash receipts rose 20% to $10.4 million, while its sales pipeline expanded to $78 million.
Victor Sage
Victor Sage
27 July 2026
Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.
Ada Torres
Ada Torres
27 July 2026
Nyrada has dosed the first patient in its Phase IIa trial of Xolatryp targeting heart attack recovery, while strengthening its cash reserves and receiving a US patent allowance for its lead drug.
Ada Torres
Ada Torres
27 July 2026
Anson Resources has applied to acquire 1,175 acres of lithium-rich brine mineral rights in Utah, aiming to boost its Green River Lithium Project and support a JORC resource upgrade in Q3 2026.
Maxwell Dee
Maxwell Dee
27 July 2026
Imricor Medical Systems has officially launched its US commercial operations, securing Rady Children’s Hospital–San Diego as the first customer for its NorthStar iMR mapping system, following key FDA clearances including pediatric approvals.
Ada Torres
Ada Torres
27 July 2026
Yowie Group has doubled its half-year profit to US$0.9 million amid a 16% revenue decline, driven by a US customer range cut and elevated cocoa costs impacting Australia. The confectionery maker advances its turnaround with new product launches and legal wins, while navigating ongoing funding and legacy loan challenges.
Victor Sage
Victor Sage
24 July 2026
EBR Systems has launched the WiSE Coupler in the US, a new accessory designed to improve the implantation of its wireless cardiac pacing electrode. The device has FDA clearance and was piloted in 10 procedures, marking another step in the company’s US commercial expansion.
Ada Torres
Ada Torres
24 July 2026